Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Grever

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Blood|October 26, 2000
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatinI W Flinn, K J Kopecky, M K Foucar, et al.
Leukemia|May 25, 2011
Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridolK A Blum, A S Ruppert, J A Woyach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicityJ C Byrd, T Murphy, R S Howard, et al.
Leukemia|January 24, 2014
Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single centerD M Stephens, A S Ruppert, J A Jones, et al.
Leukemia|July 4, 2014
Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib responseW E Pierceall, S L Warner, R J Lena, et al.
Annals of Hematology|May 6, 2004
G3139, a BCL-2 antisense oligo-nucleotide, in AMLG Marcucci, W Stock, G Dai, et al.
Leukemia|February 20, 2003
Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cellsM I Klisovic, E A Maghraby, M R Parthun, et al.
Leukemia|March 1, 2014
Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activityK P Callahan, M Minhajuddin, C Corbett, et al.
The Journal of Experimental Medicine|December 26, 2001
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemiaA Rosenwald, A A Alizadeh, G Widhopf, et al.
Nature|February 17, 2000
Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingA A Alizadeh, M B Eisen, R E Davis, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Blood|October 26, 2000
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatinI W Flinn, K J Kopecky, M K Foucar, et al.
Leukemia|May 25, 2011
Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridolK A Blum, A S Ruppert, J A Woyach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicityJ C Byrd, T Murphy, R S Howard, et al.
Leukemia|January 24, 2014
Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single centerD M Stephens, A S Ruppert, J A Jones, et al.
Leukemia|July 4, 2014
Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib responseW E Pierceall, S L Warner, R J Lena, et al.
Annals of Hematology|May 6, 2004
G3139, a BCL-2 antisense oligo-nucleotide, in AMLG Marcucci, W Stock, G Dai, et al.
Leukemia|February 20, 2003
Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cellsM I Klisovic, E A Maghraby, M R Parthun, et al.
Leukemia|March 1, 2014
Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activityK P Callahan, M Minhajuddin, C Corbett, et al.
The Journal of Experimental Medicine|December 26, 2001
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemiaA Rosenwald, A A Alizadeh, G Widhopf, et al.
Nature|February 17, 2000
Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingA A Alizadeh, M B Eisen, R E Davis, et al.
Pageof 10